• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 Fyn 抑制剂 saracatinib 治疗癫痫后状态可改善小鼠的认知功能。

Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice.

机构信息

Department of Neurology, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.

Institute of Neuroscience, Nanchang University, Nanchang, 330006, Jiangxi, China.

出版信息

BMC Neurosci. 2021 Jan 15;22(1):2. doi: 10.1186/s12868-020-00606-z.

DOI:10.1186/s12868-020-00606-z
PMID:33451301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7811255/
Abstract

BACKGROUND

Status epilepticus (SE) is a life-threatening neurological disorder. The hippocampus, as an important area of the brain that regulates cognitive function, is usually damaged after SE, and cognitive deficits often result from hippocampal neurons lost after SE. Fyn, a non-receptor Src family of tyrosine kinases, is potentially associated with the onset of seizure. Saracatinib, a Fyn inhibitor, suppresses epileptogenesis and reduces epileptiform spikes. However, whether saracatinib inhibits cognitive deficits after SE is still unknown.

METHODS

In the present study, a pilocarpine-induced SE mouse model was used to answer this question by using the Morris water maze and normal object recognition behavioral tests.

RESULTS

We found that saracatinib inhibited the loss in cognitive function following SE. Furthermore, we found that the number of hippocampal neurons in the saracatinib treatment group was increased, when compared to the SE group.

CONCLUSIONS

These results showed that saracatinib can improve cognitive functions by reducing the loss of hippocampal neurons after SE, suggesting that Fyn dysfunction is involved in cognitive deficits after SE, and that the inhibition of Fyn is a possible treatment to improve cognitive function in SE patients.

摘要

背景

癫痫持续状态(SE)是一种危及生命的神经系统疾病。海马作为调节认知功能的重要脑区,通常在 SE 后受损,而 SE 后海马神经元的丢失往往导致认知缺陷。Fyn 是一种非受体Src 家族酪氨酸激酶,可能与癫痫发作的发生有关。Saracatinib 是一种 Fyn 抑制剂,可抑制癫痫发生并减少癫痫样棘波。然而,saracatinib 是否抑制 SE 后认知缺陷仍不清楚。

方法

本研究采用匹鲁卡品诱导的 SE 小鼠模型,通过 Morris 水迷宫和正常物体识别行为测试来回答这个问题。

结果

我们发现 saracatinib 抑制了 SE 后认知功能的丧失。此外,与 SE 组相比,saracatinib 治疗组的海马神经元数量增加。

结论

这些结果表明,saracatinib 可通过减少 SE 后海马神经元的丢失来改善认知功能,提示 Fyn 功能障碍参与 SE 后认知缺陷,抑制 Fyn 可能是改善 SE 患者认知功能的一种治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd76/7811255/9cbba4997f0e/12868_2020_606_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd76/7811255/de93a7b520ec/12868_2020_606_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd76/7811255/1b057bc4258b/12868_2020_606_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd76/7811255/9fd2d569eeb0/12868_2020_606_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd76/7811255/9cbba4997f0e/12868_2020_606_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd76/7811255/de93a7b520ec/12868_2020_606_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd76/7811255/1b057bc4258b/12868_2020_606_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd76/7811255/9fd2d569eeb0/12868_2020_606_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd76/7811255/9cbba4997f0e/12868_2020_606_Fig4_HTML.jpg

相似文献

1
Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice.使用 Fyn 抑制剂 saracatinib 治疗癫痫后状态可改善小鼠的认知功能。
BMC Neurosci. 2021 Jan 15;22(1):2. doi: 10.1186/s12868-020-00606-z.
2
Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy.Fyn-PKCδ 信号在颞叶癫痫实验模型中 SE 诱导的神经炎症和癫痫发生中的作用。
Neurobiol Dis. 2018 Feb;110:102-121. doi: 10.1016/j.nbd.2017.11.008. Epub 2017 Nov 29.
3
Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy.沙卡替尼(AZD0530)在红藻氨酸诱导的颞叶癫痫大鼠模型中的疾病修饰作用机制:一种Src/Fyn 酪氨酸激酶抑制剂。
Neurobiol Dis. 2021 Aug;156:105410. doi: 10.1016/j.nbd.2021.105410. Epub 2021 Jun 1.
4
Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.沙卡替尼通过靶向Src 家族激酶成员 Fyn 减轻肝纤维化的体外和体内研究。
Cell Death Dis. 2020 Feb 12;11(2):118. doi: 10.1038/s41419-020-2229-2.
5
Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model.在阿尔茨海默病小鼠模型中,Fyn 阻断的疾病修饰益处可在冲洗后持续存在。
Neuropharmacology. 2018 Mar 1;130:54-61. doi: 10.1016/j.neuropharm.2017.11.042. Epub 2017 Nov 27.
6
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.抑制Fyn可挽救阿尔茨海默病小鼠已有的记忆和突触丧失。
Ann Neurol. 2015 Jun;77(6):953-71. doi: 10.1002/ana.24394. Epub 2015 Mar 21.
7
Tyrosine kinase Fyn promotes osteoarthritis by activating the β-catenin pathway.酪氨酸激酶 Fyn 通过激活β-catenin 通路促进骨关节炎。
Ann Rheum Dis. 2018 Jun;77(6):935-943. doi: 10.1136/annrheumdis-2017-212658. Epub 2018 Mar 19.
8
In Vivo Synaptic Density Imaging with C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease.利用 C-UCB-J 进行体内突触密度成像可检测到 Saracatinib 在阿尔茨海默病小鼠模型中的治疗效果。
J Nucl Med. 2019 Dec;60(12):1780-1786. doi: 10.2967/jnumed.118.223867. Epub 2019 May 17.
9
The Kinase Fyn As a Novel Intermediate in L-DOPA-Induced Dyskinesia in Parkinson's Disease.激酶 Fyn 作为帕金森病中 L-DOPA 诱导运动障碍的新中间物。
Mol Neurobiol. 2018 Jun;55(6):5125-5136. doi: 10.1007/s12035-017-0748-3. Epub 2017 Aug 24.
10
The Fyn kinase inhibitor, AZD0530, suppresses mouse alcohol self-administration and seeking.Fyn 激酶抑制剂 AZD0530 抑制小鼠酒精的自我给药和觅药行为。
Addict Biol. 2019 Nov;24(6):1227-1234. doi: 10.1111/adb.12699. Epub 2018 Dec 7.

引用本文的文献

1
Changes in the Proteomic Profile After Audiogenic Kindling in the Inferior Colliculus of the GASH/Sal Model of Epilepsy.癫痫GASH/Sal模型下丘听觉源性点燃后蛋白质组学图谱的变化
Int J Mol Sci. 2025 Mar 5;26(5):2331. doi: 10.3390/ijms26052331.
2
SRC family kinase inhibition rescues molecular and behavioral phenotypes, but not protein interaction network dynamics, in a mouse model of Fragile X syndrome.Src 家族激酶抑制可挽救脆性 X 综合征小鼠模型的分子和行为表型,但不能挽救其蛋白质相互作用网络动力学。
Mol Psychiatry. 2024 May;29(5):1392-1405. doi: 10.1038/s41380-024-02418-7. Epub 2024 Jan 31.
3
Exploring the benefits of in-diet versus repeated oral dosing of saracatinib (AZD0530) in chronic studies: insights into pharmacokinetics and animal welfare.

本文引用的文献

1
The dual role of c-src in cell-to-cell transmission of α-synuclein.c-src 在 α-突触核蛋白细胞间传递中的双重作用。
EMBO Rep. 2020 Jul 3;21(7):e48950. doi: 10.15252/embr.201948950. Epub 2020 May 5.
2
Seizure-induced neuroinflammation contributes to ectopic neurogenesis and aggressive behavior in pilocarpine-induced status epilepticus mice.癫痫引起的神经炎症导致匹鲁卡品诱导的癫痫持续状态小鼠的异位神经发生和攻击行为。
Neuropharmacology. 2020 Jun 15;170:108044. doi: 10.1016/j.neuropharm.2020.108044. Epub 2020 Mar 7.
3
Ryanodine receptors drive neuronal loss and regulate synaptic proteins during epileptogenesis.
在慢性研究中探索饮食中添加与重复口服给药司拉替尼(AZD0530)的益处:对药代动力学和动物福利的见解
Front Vet Sci. 2023 Nov 9;10:1297221. doi: 10.3389/fvets.2023.1297221. eCollection 2023.
4
Gut dysbiosis following organophosphate, diisopropylfluorophosphate (DFP), intoxication and saracatinib oral administration.有机磷酸酯、二异丙基氟磷酸酯(DFP)中毒及口服萨拉卡替尼后肠道菌群失调。
Front Microbiomes. 2022;1. doi: 10.3389/frmbi.2022.1006078. Epub 2022 Oct 20.
5
Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress.萨拉卡替尼,一种Src酪氨酸激酶抑制剂,在大鼠二异丙基氟磷酸酯(DFP)模型中作为疾病修饰剂:性别差异、神经行为、胶质细胞增生、神经退行性变和硝基氧化应激。
Antioxidants (Basel). 2021 Dec 28;11(1):61. doi: 10.3390/antiox11010061.
6
Differential Impact of Severity and Duration of , Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model.在大鼠二异丙基氟磷酸酯模型中,医学对策、疾病修饰剂萨拉卡替尼的严重程度和持续时间对脑区的差异影响。
Front Cell Neurosci. 2021 Oct 15;15:772868. doi: 10.3389/fncel.2021.772868. eCollection 2021.
7
Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy.沙卡替尼(AZD0530)在红藻氨酸诱导的颞叶癫痫大鼠模型中的疾病修饰作用机制:一种Src/Fyn 酪氨酸激酶抑制剂。
Neurobiol Dis. 2021 Aug;156:105410. doi: 10.1016/j.nbd.2021.105410. Epub 2021 Jun 1.
8
Preclinical Assessment of a New Hybrid Compound C11 Efficacy on Neurogenesis and Cognitive Functions after Pilocarpine Induced Status Epilepticus in Mice.临床前评估新型杂交化合物 C11 对匹罗卡品诱导的癫痫持续状态后小鼠神经发生和认知功能的疗效。
Int J Mol Sci. 2021 Mar 22;22(6):3240. doi: 10.3390/ijms22063240.
肌质网钙释放通道在癫痫发生过程中驱动神经元丢失并调节突触蛋白。
Exp Neurol. 2020 May;327:113213. doi: 10.1016/j.expneurol.2020.113213. Epub 2020 Jan 24.
4
Fyn gene silencing reduces oligodendrocytes apoptosis through inhibiting ERK1/2 phosphorylation in epilepsy.Fyn 基因沉默通过抑制癫痫中 ERK1/2 磷酸化减少少突胶质细胞凋亡。
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):298-304. doi: 10.1080/21691401.2019.1671428.
5
Propionate relieves pentylenetetrazol-induced seizures, consequent mitochondrial disruption, neuron necrosis and neurological deficits in mice.丙酸盐可缓解戊四氮诱发的小鼠癫痫发作、随后的线粒体损伤、神经元坏死和神经功能缺损。
Biochem Pharmacol. 2019 Nov;169:113607. doi: 10.1016/j.bcp.2019.08.009. Epub 2019 Sep 3.
6
Frontotemporal dementia mutant Tau promotes aberrant Fyn nanoclustering in hippocampal dendritic spines.额颞叶痴呆突变型 Tau 促进海马树突棘中异常 Fyn 纳米簇的形成。
Elife. 2019 Jun 25;8:e45040. doi: 10.7554/eLife.45040.
7
Losmapimod Protected Epileptic Rats From Hippocampal Neuron Damage Through Inhibition of the MAPK Pathway.洛索匹明通过抑制丝裂原活化蛋白激酶(MAPK)信号通路保护癫痫大鼠的海马神经元免受损伤。
Front Pharmacol. 2019 Jun 7;10:625. doi: 10.3389/fphar.2019.00625. eCollection 2019.
8
Aβ oligomers promote oligodendrocyte differentiation and maturation via integrin β1 and Fyn kinase signaling.Aβ 寡聚物通过整合素 β1 和 Fyn 激酶信号促进少突胶质细胞分化和成熟。
Cell Death Dis. 2019 Jun 6;10(6):445. doi: 10.1038/s41419-019-1636-8.
9
In Vivo Synaptic Density Imaging with C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease.利用 C-UCB-J 进行体内突触密度成像可检测到 Saracatinib 在阿尔茨海默病小鼠模型中的治疗效果。
J Nucl Med. 2019 Dec;60(12):1780-1786. doi: 10.2967/jnumed.118.223867. Epub 2019 May 17.
10
Immunohistochemical Study of Antioxidant Enzymes Regulated by Nrf2 in the Models of Epileptic Seizures (KA and PTZ).Nrf2 调控的抗氧化酶在癫痫发作模型(KA 和 PTZ)中的免疫组化研究。
Oxid Med Cell Longev. 2019 Mar 24;2019:1327986. doi: 10.1155/2019/1327986. eCollection 2019.